FDA approves CSL's Kcentra

FDA approved a BLA late Monday from CSL Ltd. (ASX:CSL) for Kcentra for the urgent reversal of anticoagulation with vitamin K antagonist therapy, including warfarin, in adults with acute major bleeding...